astrazeneca glp-1 AstraZeneca's Bydureon gets a facelift, but can it stand out in a market that's only getting tougher? astrazeneca glp 1 pipeline Market

BPC-157: The Healing Peptide Everyone's Talking About (What We Actually Know) BPC-157 is one of the most-discussed peptides on social media, with claims of accelerated tendon healing, gut repair, and neuroprotection -- but the honest reality is that the evidence comes almost entirely from animal studies, with essentially no completed human clinical trials to back the widespread claims

Individuals with kidney disease, copper metabolism disorders, or active infections should consult providers before use

Fasting blood was collected at baseline, after 3 and 6 wk of supplementation, and again after a 4-wk washout period

Bodily Autonomy Every client has the right to make decisions about their body without coercion

Peripheral neuropathy under oncologic therapies: a literature review on pathogenetic mechanisms

The team highlights a patent-pending peptide and yeast delivery platform, cGMP manufacturing, and third-party testing for identity, purity, and potency